Clinical Trials in CNS November 22, 2011

SMI is proud to present the 10th annual conference…

Clinical Trials in CNS
23rd & 24th November 2011, Marriott Hotel Regent’s Park, Central London, UK

http://www.smi-online.co.uk/2011cnstrials21.asp

SMi is delighted to announce its 10th annual Clinical Trials in CNS conference, bringing together leading industry experts to explore the current and future opportunities within CNS drug development. This conference aims to cover clinical drug discovery activities, new therapeutic targets, as well as effective CNS drug development strategies and problems encountered in clinical trials, with in-depth discussions and case study presentations from the key industry players.

Focusing on a wide range of therapeutic areas such Multiple Sclerosis, Parkinson’s and Alzheimer’s, as well as analysing psychiatric disorders schizophrenia and depression, this event will be a valuable opportunity to discuss with industry leaders the current landscape in clinical CNS drug development, as well as leaning about some of the most cutting edge translational research.

Our confirmed speakers include:

• Georg Terstappen, Director and Department Head, Neuroscience Discovery, Abbott
• Florien von Raison , Head of ,Global Clinical Development Unit Parkinson’s Disease, Merck Serono
• Peter Joseph Jongen, Founding Director, MS4 Research Institute
• Sophie Dix, Senior Research Scientist, Neurodegenerative Diseases Drug Hunting Team, Lilly
• Ge Ruigt, Director Experimental Medicine Neuroscience, Merck
• Paul Thompson, Associate, Director Discovery Medicine Unit, GSK
• Hitendra Parmar, European Medical Director for Alzheimer’s Disease, Pfizer
• Chas Bountra, Chief Scientist, Structural Genomics Consortium, University of Oxford
• David Dexter, Reader in NeuroPharmacology Department of Medicine, Imperial College London

PLUS: AN INTERACTIVE HALF-DAY PRE-CONFERENCE WORKSHOP
Innovation, superiority and best practice proof-of-concept in CNS clinical development
22th November 2011 Marriott Regent’s Park, London
Erik Buntinx, CEO – Managing Director, PharmaNeuroBoost

Visit http://www.smi-online.co.uk/2011cnstrials21.asp to register!

Sponsorship and Exhibition Opportunities are available

To find out more, contact Alia Malick - Head of Pharmaceuticals

On tel: +44 (0)20 7827 6168 or email: [email protected]

Booking Information

http://www.smi-online.co.uk/2011cnstrials21.asp

Alternatively contact Zain Philbey on Tel: +44 (0) 20 7827 6722 or email: [email protected]

Official Website: http://www.smi-online.co.uk/2011cnstrials21.asp